Incyte rises on Jakafi pancreatic cancer study - Businessweek

[INCIID News Feed]

<img alt="" height="1" width="1" />
Incyte rises on Jakafi pancreatic cancer study
Businessweek
NEW YORK (AP) — Shares of Incyte jumped Wednesday after the company said its drug Jakafi helped improve survival for patients with pancreatic cancer. The biopharmaceutical company said patients treated with Jakafi and the chemotherapy drug Xeloda ...
UPDATED: Incyte shares soar on positive pancreatic cancer trial data for JakafiFierceBiotech
Incyte Sees Improved Survival for Certain Patients in Pancreatic Cancer StudyWall Street Journal
Incyte PharmaStock Soars As Drug Fights Pancreatic Cancer INCYInvestor's Business Daily
Reuters -Benzinga -Motley Fool
all 15 news articles &raquo;


More...